Delisting risk
SciSparc (SPRC)
Develops cannabinoid drug candidates and sells Wellution hemp and personal-care products through Amazon.
$5.76
Pre-market−0.08 (−1.37%)
At close$5.84(+3.00%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions3 holders · as of Mar 31, 2026 | 5.67% | 3.3K ADS | |
| Insiders9 holders · as of Jul 13, 2026 | 8.14% | 4.7K ADS | |
| Otherremainder | 86.19% | 49.9K ADS |
57.8K ADS (1 ADS = 12 ordinary shares) as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count is from the company's Dec 2023 annual report; nothing newer is on file here.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Institutions13F, as of Mar 31, 2026
3 holders · 3.3K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| UBS Group AG | 3.1K | 5.44% | May 5, 2026 | |
| Strategic Investment Solutions, Inc. /IL | 133 | 0.23% | May 1, 2026 | |
| Sbi Securities Co., Ltd. | 1 | 0.00% | Apr 28, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 1, 2026 | Itschak Shremdirector | Sale | 462 | $10.00 | 10,596 |
CongressHouse and Senate disclosures
Not reported.